Posts

After FDA sign-off, Colorado's drug import plan faces tough road ahead

Colorado has received FDA authorization to import certain prescription drugs from Canada, becoming the second state to do so, but faces significant hurdles in building the supply chain and securing manufacturer participation. The FDA’s two-year authorization requires Colorado to file pre-import requests for specific drugs within a year, or the program could be terminated, adding pressure on the state to move quickly. Analyses estimate potential savings of tens of millions of dollars over several years, yet industry skepticism, logistical challenges, and past federal delays suggest the program’s full launch may still be uncertain and difficult to sustain. Sources: 'A big step': Colorado gets FDA OK to import cheaper drugs ... [PDF] Colorado's Drug Importation Program: 2024 Annual Report Colorado is at odds with the feds over prescription drug importation FDA allows Colorado drug imports, in theory FDA approves Colorado's plan to import cheaper drugs from ...

Novo Nordisk hit by multi‑million‑dollar ransom demands after major data breach claimed by hacking groups

UniQure stock surges after FDA U-turn clears path to gene therapy filing

Despite 'decent' data, Verastem rethinks options for approved oncology combo in pancreatic cancer

Jazz partners with AbCellera on T-cell engager programs for GI cancers in deal valued up to $4.1B, with $56M upfront and up to $792M in milestones per program, plus tiered royalties on net sales spanning mid-single-digit to low double-digit percentages.

Merck adds to biopharma’s AI agenda with up to $510M+ Protillion pact

Lilly bolsters non‑opioid pain portfolio with 4E Therapeutics buy

Migraine biotech makes its debut with $46M to advance preclinical pipeline

Oncolytics Biotech Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044

Lilly’s Jaypirca scores another Phase III win in CLL, but use with Venclexta still evolving in practice

Can Intellia's lonvo-z Turn CRISPR Promise into HAE Practice?

Elicio pancreatic cancer vaccine misses Phase II primary endpoint but shows post-hoc signal in resected patients

General-purpose large language models outperform specialized clinical AI tools on medical benchmarks, Nature Medicine study finds